NLB Skladi, upravljanje premozenja, d.o.o.
Position in JNJ — Johnson & Johnson
CIK 2110897
Ljubljana, 2A
Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$18,005,711
+$2,251,309 QoQ
Shares Held
70,897
+10.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#792
of 4,676 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NLB Skladi, upravljanje premozenja, d.o.o. holds $123,132,614 across 11 Drug Manufacturers - General names. JNJ ranks #3 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,936 | $43,102,720 | |
| 2 | ABBV |
AbbVie Inc.
|
73,057 | $18,384,063 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
70,897 | $18,005,711 | |
| 4 | AZN |
Astrazeneca PLC
|
81,023 | $15,363,581 | |
| 5 | MRK |
Merck & Co., Inc.
|
93,000 | $11,950,500 | |
| 6 | AMGN |
Amgen Inc
|
13,327 | $4,825,973 | |
| 7 | PFE |
Pfizer Inc
|
163,956 | $3,948,060 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
28,587 | $3,611,681 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,005,711 | 70,897 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $15,754,402 | 64,451 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $14,497,261 | 70,052 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||